Trial no.:
|
PACTR201812794533961 |
Date of Approval:
|
12/12/2018 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Infraclavicular–SubOmohyoid (ISO) block versus interscalene brachial plexus block |
Official scientific title |
Infraclavicular–SubOmohyoid (ISO) block versus interscalene brachial plexus block; diaphragmatic excursion and perioperative analgesia: a prospective randomized trial |
Brief summary describing the background
and objectives of the trial
|
Shoulder surgery typically results in moderate to severe postoperative pain, especially within the first 24 h after surgery. [1] The interscalene block is one of the most effective analgesic techniques for shoulder surgery. Compared with other techniques, it provides superior analgesia and reduced opioid-related adverse effects. [2] However, it may be associated with a 100% incidence of ipsilateral hemidiaphragmatic paresis, resulting from a phrenic nerve block. [3,4] This side effect potentially undermines the benefit of regional anesthesia for patients suffering from moderate to severe respiratory dysfunction. [5-7] In addition, the interscalene block is associated with a higher risk of transient neurological symptoms than other peripheral nerve blocks. [8] To bypass this complication, distal block of the shoulder innervation is recommended. [9]
Blocking the axillary nerve and suprascapular nerve can provide adequate analgesia for minor shoulder surgery, but for major surgery both infraclavicular and suprascapular nerve blocks are required. [9] To minimize block time and patient discomfort, both infraclavicular and suprascapular nerve blocks can be performed with a single-puncture technique (the ISO block).
The ISO block anaesthetizes the entire innervation of the shoulder joint and muscles. By adding skin infiltration at incision, a totally opioid-free anesthetic can be achieved.
The aim of this prospective randomized trial is to compare the effects of ISO block versus interscalene block on diaphragmatic excursion as a primary outcome and analgesia and pulmonary function as secondary outcomes in patients undergoing shoulder surgery.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Orthopaedics,perioperative analgesia for shoulder surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
15/12/2018 |
Actual trial start date |
20/01/2019 |
Anticipated date of last follow up |
15/06/2019 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|